Itraconazole cyclodextrin solution: The role of in vitro susceptibility testing in predicting successful treatment of HIV-related fluconazole-resistant and fluconazole-susceptible oral candidosis

AIDS

Volumn 11, Issue 2, 1997, Pages 163-168

  Cartledge, Jonathan D ^a   Midgley, Jennifer ^a   Gazzard, Brian G ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Candidosis; HIV; Itraconazole; Susceptibility testing

Indexed keywords

ANTIFUNGAL AGENT; CYCLODEXTRIN; FLUCONAZOLE; ITRACONAZOLE;

ARTICLE; DRUG SCREENING; DRUG SENSITIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MIXED INFECTION; PRIORITY JOURNAL; THRUSH;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS, ORAL; CD4 LYMPHOCYTE COUNT; DRUG RESISTANCE, MICROBIAL; FLUCONAZOLE; HIV INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; SENSITIVITY AND SPECIFICITY;

EID: 0031015794     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199702000-00005     Document Type: Article

References (11)

1. Cartledge JD, Midgley J, Gazzard BG: Relative Growth Measurement of Candida species in a single concentration of fluconazole predicts clinical response to fluconazole in patients with HIV-related oral candidosis. J Antimicrob Chemother 1996, 34:247-252.
2. Odds FC: Antifungal susceptibility testing of Candida species by relative growth measurement at single concentrations of anti-fungal agents. Antimitrob Agents Chemother 1992, 36:1727-1737.
3. Cartledge JD, Midgley I, Youle M, Gazzard BG: The use of cyclodextrin solution of itraconazole for oral and oesophageal candidosis unresponsive to other azole anti-fungals in HIV-positive patients. IXth International Conference on AIDS. Berlin, June 1993 [abstract WS-B-12-2].
4. Lake-Bakaar G, Winston T, Lake-Bakaar D, et al.: Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome (AIDS). Ann Int Med 1988, 109:471-473.
5. Cartledge JD, Midgley J, Youle M, Gazzard BG: Itraconazole cyclodextrin solution; effective treatment for HIV-related candidosis unresponsive to other azole therapy. J Antimicrob Chemother 1994, 33:1071-1073.
6. Henderson AR: Assessing test accuracy and its clinical consequences: a primer for receiver operating characteristic curve analysis. Ann Clin Biochem 1993, 30:521-539.
7. Dronda F, Chaves F, Alonso-Sanz M, et al.: Clinical significance of mixed oropharyngeal candidiasis due to Candida albicans and non-albicans strains in HIV-infected patients. 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. Orlando, October 1994 [abstract 1-215].
8. Vanden Bossche H, Marichal P, Gorrens J, Bellens D, Moereels H, Janssen PAJ: Mutation of cytochrome p450 dependent 14 alpha demethylase results in decreased affinity for azole anti-fungals. Biochem Soc Trans 1990, 18:56-59.
9. Vanden Bossche H, Marichal P, Odds FC, Le Jeune L, Coone MC: Characterisation of an azole resistant Candida glabrata isolate. Antimicrob Agents Chemother 1992, 36:2602-2610.
10. Hitchcock CA, Pye GW, Troke PF, Johnson EM, Warnock DW: Fluconazole resistance in Candida glabrata. Antimicrob Agents Chemother 1993, 37:1962-1965.
11. National Committee for Clinical Laboratory Standards: Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Proposed stjmtjrd M27-P. Villanova: National Committee for Clinical Laboratory Standards; 1992.